RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Ceapro % OwnershipA double digit share price would start at a 770 mil market cap.
If any one of the several market opportunities we are looking at (aside from Juvente) really works, we could expect at least that market cap.
If the covid inhalation treatment works and gets approved and helps people, that is worth a goodly multiple on a 770 mil market cap.